Life Sciences market research reports by Digital Vector

Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD

Nov 01, 2017  |  Published by: Digital Vector  |  USD 6,995

Frontier Pharma: Neurodegenerative Diseases - Protein Misfolding Targets and Neuromodulators Dominate the First-in-Class Pipeline and Lead the Way as Potential Disease-Modifying Therapies in AD and PD Summary Neurodegenerative diseases are becoming increasingly prevalent due to an aging population, ... Read More